Know Cancer

forgot password

Phase 2
18 Years
Not Enrolling
Cancer Cachexia

Thank you

Trial Information

Inclusion Criteria:

- Community-dwelling patients ≥ 18 years of age with incurable,histologically diagnosed

- Involuntary loss of body weight of ≥ 5 % within the past 6 months

Exclusion Criteria:

- Presently hospitalized or in a nursing care facility.

- Inability to increase food intake from secondary causes.

- Liver disease

- If female-pregnant, breast-feeding or of childbearing potential.

Type of Study:


Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind

Outcome Measure:

Body weight

Principal Investigator

William Polvino, MD

Investigator Role:

Study Director

Investigator Affiliation:

Helsinn Therapeutics (U.S.), Inc


United States: Food and Drug Administration

Study ID:




Start Date:

November 2005

Completion Date:

October 2006

Related Keywords:

  • Cancer Cachexia
  • Cachexia



South Carolina Oncology Associates Columbia, South Carolina  29201
Kenmar Research Institute Los Angeles, California  90057
Charleston Cancer Center Charleston, South Carolina  29406
PAB Clinical Research Brandon, Florida  33511
Hematology Oncology Consultants, Inc. Columbus, Ohio  43235
Bay Area Oncology Tampa, Florida  33607
Center for Cancer and Blood Disorders Bethesda, Maryland  20817
Multicare Health System Tacoma, Washington  98415
South Carolina Cancer Specialists Hilton Head Island, South Carolina  29925
Pacific Oncology & Hematology Associates Encinitas, California  92024
Melbourne Internal Medicine Associates Melbourne, Florida  32901
Pacific Oncology and Hematology Associates San Diego, California  92024
Palo Verde Hematology Oncology Ltd. Glendale, Arizona  85304
Comprehensive Blood & Cancer Center Bakersfield, California  93309
Advanced Medical Research Institute Fresno, California  93710
Kenmar Clinical Research Los Angeles, California  90057
Sant Chawla, Inc. Santa Monica, California  90403
Osler Medical, Inc./ Osler Clinical Research Melbourne, Florida  32901
University of Texas Medical Texas Galveston, Texas  77555